Dementia webinar, your feedback + drug benefit updates
Complete Provider Satisfaction Survey by August 28!
We want to hear from you! As one of our valued providers, we appreciate your thoughtful feedback and insights.
Be on the lookout: Press Ganey, formerly known as SPH Analytics, will be mailing out the Provider Satisfaction Survey beginning in June, followed by telephone surveys in July and August. Responses are due by August 28.
The survey measures overall provider satisfaction with the Alliance, as well as satisfaction in areas such as:
- Claims payment and processing.
- Health care services.
- Coordination of care.
- Health plan call center staff.
- Provider relations.
- Access to urgent and routine care.
- Cultural and Linguistic Services.
- Community care coordination.
- The Provider Portal.
Key findings and trends are closely tracked, and we use feedback to inform short-term and long-term initiatives.
Thank you in advance to all provider offices taking the time to participate in the survey. We appreciate your candid feedback and partnership to provide accessible, quality health care guided by local innovation!
Dementia webinar: Cognitive Health Assessment for Adults Experiencing Homelessness
Please join us for the Dementia Care Aware initiative’s next webinar, “Adapting the Cognitive Health Assessment for Adults Experiencing Homelessness.”
June 23, 2023
2–3 p.m. on Zoom
About the webinar
Serggio Lanata, MD, MS, associate professor of clinical neurology at the University of California, San Francisco and director of the UCSF Memory and Aging Center Community Outreach Program, will join us to speak on the topic.
Those who participate in the live webinar are eligible to receive 1 Continuing Medical Education (CME) credit, California Association of Marriage and Family Therapists (CAMFT) credit, American Academy of Family Physicians (AAFP) credit and Maintenance of Certification (MOC) credit.
Physician-administered drug changes effective June 1, 2023
Effective June 1, 2023, the Alliance will be implementing changes to the physician-administered drug benefit. These changes have been reviewed and approved by the Pharmacy & Therapeutics (P&T) Committee. The changes are as follows:
|J1437||Ferric derisomaltose||Require a prior authorization|
|J7336||Capsaicin 8%||Require a prior authorization|
|Q5111||Pegfilgrastim-cbqv (Udenyca)||Require a prior authorization|
|J2506||Pegfilgrastim (Neulasta)||Modified prior authorization criteria|
|Q5127||Pegfilgrastim-fpgk (Stimufend)||Modified prior authorization criteria|
|Q5130||Pegfilgrastim-pbbk (Fylnetra)||Modified prior authorization criteria|
|J2778||Ranibizumab (Lucentis)||Modified prior authorization criteria|
|Q5128||Ranibizumab-eqrn (Cimerli)||Modified prior authorization criteria|
Prior authorization criteria can be found on the Alliance website.
If you have questions, please contact the Alliance Pharmacy Department at 831-430-5507.